CN106109909A - 一种用于防治糖尿病和高血压的组合物 - Google Patents
一种用于防治糖尿病和高血压的组合物 Download PDFInfo
- Publication number
- CN106109909A CN106109909A CN201610553188.1A CN201610553188A CN106109909A CN 106109909 A CN106109909 A CN 106109909A CN 201610553188 A CN201610553188 A CN 201610553188A CN 106109909 A CN106109909 A CN 106109909A
- Authority
- CN
- China
- Prior art keywords
- parts
- compositions
- rhizoma
- hypertension
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 22
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 14
- 241001112361 Leucocalocybe mongolica Species 0.000 claims abstract description 12
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 9
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 9
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims abstract description 9
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 9
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 9
- 235000012661 lycopene Nutrition 0.000 claims abstract description 9
- 229960004999 lycopene Drugs 0.000 claims abstract description 9
- 239000001751 lycopene Substances 0.000 claims abstract description 9
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims abstract description 9
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 9
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims abstract description 9
- 229960002675 xylitol Drugs 0.000 claims abstract description 9
- 235000010447 xylitol Nutrition 0.000 claims abstract description 9
- 239000000811 xylitol Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 229930182490 saponin Natural products 0.000 claims abstract description 8
- 235000017709 saponins Nutrition 0.000 claims abstract description 8
- 239000002023 wood Substances 0.000 claims abstract description 8
- 241001672694 Citrus reticulata Species 0.000 claims abstract description 7
- 235000009815 Momordica Nutrition 0.000 claims abstract description 7
- 241000218984 Momordica Species 0.000 claims abstract description 7
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 7
- 229930003944 flavone Natural products 0.000 claims abstract description 7
- 150000002212 flavone derivatives Chemical class 0.000 claims abstract description 7
- 235000011949 flavones Nutrition 0.000 claims abstract description 7
- 150000007949 saponins Chemical class 0.000 claims abstract description 7
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229920002752 Konjac Polymers 0.000 claims abstract description 6
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 5
- 235000013402 health food Nutrition 0.000 claims description 3
- 241001520921 Leersia virginica Species 0.000 claims 1
- 230000007306 turnover Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 12
- 210000004369 blood Anatomy 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 10
- 239000003814 drug Substances 0.000 abstract description 9
- 230000036772 blood pressure Effects 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 abstract 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 abstract 1
- 244000205754 Colocasia esculenta Species 0.000 description 4
- 235000006481 Colocasia esculenta Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 3
- 235000017491 Bambusa tulda Nutrition 0.000 description 3
- 241001330002 Bambuseae Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 3
- 239000011425 bamboo Substances 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 231100000460 acute oral toxicity Toxicity 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000006362 insulin response pathway Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- -1 melon Saponin Chemical class 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种用于防治糖尿病和高血压的组合物,按重量份数计,所述组合物的主要原料为:魔芋精粉40~50份、口蘑20~30份、牛肝菌15~20份、白背三七10~15份、翻白草10~13份、北豆根6~9份、防汉己6~9份、玉竹4~6份、蒺藜3~4份、黄毛楤木3~5份、潺槁树根5~7份、沙蓬3~5份、番茄红素1~2份、苦瓜皂甙0.5~1.5份、柑橘皮黄酮0.5~1份、木糖醇1~2份和L‑阿拉伯糖1~2份。本发明利用中药之间各组分的协同作用,同时起到了降血糖和降血压的功效,并且食用安全,没有任何毒副作用,可以长期食用。
Description
技术领域
本发明属于保健食品领域,具体涉及一种用于防治糖尿病和高血压的组合物。
背景技术
随着人们水平的提高,人们的生活节奏也越来越快,并且由于工作压力等,造成了现代人生活不规律、缺乏运动,此外,快餐行业的快速发展,也使得现代人饮食越来越趋于不健康化,这些都成为了糖尿病和高血压并发的诱因,并且有越来越年轻化的趋势。糖尿病和高血压作为危及人类健康和生命的两种常见慢性病,二者的关系很复杂,常同时存在。
由于糖尿病和高血压为慢性疾病,治疗周期长,长期服用西药,不仅价格昂贵,而且副作用比较大,患者不仅长期忍受着头晕、疲乏、心悸的折磨,而且血压居高不下,对心脑肾的伤害日趋严重,患者面临着心肌梗死、脑中风、肾衰竭的危险。因此,需要一种能起到较好的预防和治疗作用,而且无副作用,可以长期食用的药物或食品。
发明内容
本发明的目的在于针对现有技术不足,提供一种用于防治糖尿病和高血压的组合物。本发明利用中药之间各组分的协同作用,同时起到了降血糖和降血压的功效,并且食用安全,没有任何毒副作用,可以长期食用。
为实现上述目的,本发明采用如下技术方案:
一种用于防治糖尿病和高血压的组合物,按重量份数计,所述组合物的主要原料为:魔芋精粉40~50份、口蘑20~30份、牛肝菌15~20份、白背三七10~15份、翻白草10~13份、北豆根6~9份、防汉己6~9份、玉竹4~6份、蒺藜3~4份、黄毛楤木3~5份、潺槁树根5~7份、沙蓬3~5份、番茄红素1~2份、苦瓜皂甙0.5~1.5份、柑橘皮黄酮0.5~1份、木糖醇1~2份和L-阿拉伯糖1~2份。
优选的,一种用于防治糖尿病和高血压的组合物,按重量份数计,所述组合物的主要原料为:魔芋精粉45份、口蘑25份、牛肝菌18份、白背三七12份、翻白草11份、北豆根8份、防汉己8份、玉竹5份、蒺藜3份、黄毛楤木4份、潺槁树根6份、沙蓬4份、番茄红素1份、苦瓜皂甙1份、柑橘皮黄酮0.7份、木糖醇1.5份和L-阿拉伯糖1.5份。
如上所述的用于防治糖尿病和高血压的组合物,可添加到食品中,制成健康食品。
本发明的有益效果在于:
(1)本发明的组合物在具有降血糖功效的魔芋精粉中加入了中药成分,利用中药之间各组分的协同作用,同时起到了降血糖和降血压的功效,并且食用安全,没有任何毒副作用,可以长期食用;
(2)本发明加入了口蘑和牛肝菌,利用这两种菌类所含有的具有调节功能的维生素和矿物质元素,参与体内糖代谢,降低血糖,并能调节血脂,降低血液黏稠度;此外,口蘑和牛肝菌种所含有的微量元素铬,是与胰岛素配合的因子之一,可促进机体糖代谢的正常运行;此外,口蘑和牛肝菌还能补充糖尿病、高血压患者所缺少的维生素D,预防骨质疏松。
具体实施方式
以下结合具体实施例对本发明做进一步说明,但本发明不仅仅限于这些实施例。
实施例1
一种用于防治糖尿病和高血压的组合物,按重量份数计,所述组合物的主要原料为:魔芋精粉40份、口蘑20份、牛肝菌15份、白背三七10份、翻白草10份、北豆根6份、防汉己6份、玉竹4份、蒺藜3份、黄毛楤木3份、潺槁树根5份、沙蓬3份、番茄红素1份、苦瓜皂甙0.5份、柑橘皮黄酮0.5份、木糖醇1份和L-阿拉伯糖1份。
实施例2
一种用于防治糖尿病和高血压的组合物,按重量份数计,所述组合物的主要原料为:魔芋精粉45份、口蘑25份、牛肝菌18份、白背三七12份、翻白草11份、北豆根8份、防汉己8份、玉竹5份、蒺藜3份、黄毛楤木4份、潺槁树根6份、沙蓬4份、番茄红素1份、苦瓜皂甙1份、柑橘皮黄酮0.7份、木糖醇1.5份和L-阿拉伯糖1.5份。
实施例3
一种用于防治糖尿病和高血压的组合物,按重量份数计,所述组合物的主要原料为:魔芋精粉50份、口蘑30份、牛肝菌20份、白背三七15份、翻白草13份、北豆根9份、防汉己9份、玉竹6份、蒺藜4份、黄毛楤木5份、潺槁树根7份、沙蓬5份、番茄红素2份、苦瓜皂甙1.5份、柑橘皮黄酮1份、木糖醇2份和L-阿拉伯糖2份。
上述实施例1-3所述的一种用于防治糖尿病和高血压的组合物,其制备方法如下:
(1)将白背三七、翻白草、北豆根、防汉己、玉竹、蒺藜、黄毛楤木、潺槁树根和沙蓬先用乙醇回流提取,收集醇提有效成分,将醇提后剩余的药渣用沸水提取,收集水提的有效成分,合并醇提和水提的有效成分并浓缩得浸膏,将所得浸膏喷雾干燥得中药复合粉末;
(2)将口蘑和牛肝菌洗净并晾干后进行超微粉碎,将所得粉末混合并辐照灭菌,得到复合菌粉;
(3)将魔芋精粉、步骤(1)制得的中药复合粉末、步骤(2)制得的复合菌粉、番茄红素、苦瓜皂甙、柑橘皮黄酮、木糖醇和L-阿拉伯糖混合均匀后,制得所述组合物。
利用现有成熟的工艺,将本发明制得的用于防治糖尿病和高血压的组合物添加到食品中,制成健康食品,改善血流状况,增强胰岛素反应,起到降低血糖和血压的作用。
一、药物毒性实验
将实施例1~实施例3得到的组合物进一步加入药用辅料然后用冲压装置压制成片,制得含片剂,每片0.3克。
急性经口毒性试验:该品按卫生部《化妆品卫生规范》 (2002年版 )“急性经口毒性试验中一次限量试验法”,一次经口给予小白鼠(体重18g~22g),30只,将获得的实施例1-3的含片剂分别用蒸馏水溶解,获得灌胃量20ml/kg,每个实施例经口分别给予10只小白鼠,观察 15 天,试验动物未发现中毒表现、无死亡,处死后解剖未明显异常,判断该品对小鼠急性经口毒性属实际无毒级。
二、效果测试
随机抽取90名同时患有糖尿病、高血压的患者,男40名,女50名,年龄30~55岁。服用由本发明组合物制得的含片剂,一日三次,持续6个月,对照组不服用本发明药物,结果如表1所示:
表1 血糖含量、血压值测定
从表1可以看出,6个月后服用本发明的患者,其血糖含量平均值和血压平均值都回到了正常水平,其中实施例2的效果最好;而未服用药物的对照组的血糖含量和血压值仍然高于正常水平。由此可见,本发明的用于防治糖尿病和高血压的组合物能够改善血流状况,起到降低血糖和血压的作用。
以上所述仅为本发明的较佳实施例,凡依本发明申请专利范围所做的均等变化与修饰,皆应属本发明的涵盖范围。
Claims (3)
1.一种用于防治糖尿病和高血压的组合物,其特征在于:按重量份数计,所述组合物的主要原料为:魔芋精粉40~50份、口蘑20~30份、牛肝菌15~20份、白背三七10~15份、翻白草10~13份、北豆根6~9份、防汉己6~9份、玉竹4~6份、蒺藜3~4份、黄毛楤木3~5份、潺槁树根5~7份、沙蓬3~5份、番茄红素1~2份、苦瓜皂甙0.5~1.5份、柑橘皮黄酮0.5~1份、木糖醇1~2份和L-阿拉伯糖1~2份。
2.根据权利要求1所述的用于防治糖尿病和高血压的组合物,其特征在于:按重量份数计,所述组合物的主要原料为:魔芋精粉45份、口蘑25份、牛肝菌18份、白背三七12份、翻白草11份、北豆根8份、防汉己8份、玉竹5份、蒺藜3份、黄毛楤木4份、潺槁树根6份、沙蓬4份、番茄红素1份、苦瓜皂甙1份、柑橘皮黄酮0.7份、木糖醇1.5份和L-阿拉伯糖1.5份。
3.一种如权利要求1-2所述的用于防治糖尿病和高血压的组合物的应用:其特征在于:所述组合物添加到食品中,制成健康食品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610553188.1A CN106109909A (zh) | 2016-07-14 | 2016-07-14 | 一种用于防治糖尿病和高血压的组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610553188.1A CN106109909A (zh) | 2016-07-14 | 2016-07-14 | 一种用于防治糖尿病和高血压的组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106109909A true CN106109909A (zh) | 2016-11-16 |
Family
ID=57283798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610553188.1A Pending CN106109909A (zh) | 2016-07-14 | 2016-07-14 | 一种用于防治糖尿病和高血压的组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106109909A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107183696A (zh) * | 2017-07-19 | 2017-09-22 | 北京加康生物技术有限公司 | 一种保健食品及其制备方法 |
CN108295150A (zh) * | 2017-01-12 | 2018-07-20 | 李杨 | 一种治疗糖尿病的药物及其制备方法 |
-
2016
- 2016-07-14 CN CN201610553188.1A patent/CN106109909A/zh active Pending
Non-Patent Citations (2)
Title |
---|
肖更生等: "柑橘皮黄酮降血糖作用的研究", 《现代食品科技》 * |
肖秋生等: "《家常菜里的降血糖小偏方》", 31 July 2014, 吉林科学技术出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108295150A (zh) * | 2017-01-12 | 2018-07-20 | 李杨 | 一种治疗糖尿病的药物及其制备方法 |
CN107183696A (zh) * | 2017-07-19 | 2017-09-22 | 北京加康生物技术有限公司 | 一种保健食品及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104645091A (zh) | 一种治疗高血压的胶囊 | |
CN107581543A (zh) | 一种降血糖复合冲剂 | |
CN112546167A (zh) | 一种具有健脾利湿功能的中药组合物及其制备方法和应用 | |
CN106177183A (zh) | 一种包含青钱柳叶、绿茶和桑叶的降血糖保健组合物 | |
CN106176953A (zh) | 一种包含青钱柳叶、罗汉果和桑叶的降血糖保健组合物 | |
CN106109909A (zh) | 一种用于防治糖尿病和高血压的组合物 | |
CN101279034B (zh) | 一种内服和外用结合治疗糖尿病的组合中药及制备方法 | |
CN107468952A (zh) | 一种具有辅助降血糖功能的药食同源组合物的制备方法 | |
CN102552828B (zh) | 一种护肝药物及其制备方法 | |
US11957726B2 (en) | Pharmaceutical composition for controlling blood sugar | |
CN105770606A (zh) | 一种治疗ⅱ型糖尿病及其并发症的药物组合物及其制备方法 | |
CN105796888A (zh) | 中药瘦身按摩膏 | |
CN105963201A (zh) | 一种药食两用降糖牙膏及其制备方法 | |
CN101530559A (zh) | 一种具有减肥作用的组合物 | |
CN104547022A (zh) | 一种清热润肺和利咽解毒的中药组合物 | |
CN104000180A (zh) | 一种辅助降血糖的人参组合物、制备方法及其用途 | |
CN108295023A (zh) | 一种中药牙膏及其制备方法 | |
CN103705868B (zh) | 一种治疗甲状腺功能亢进的药物组合物及其应用 | |
CN102793798A (zh) | 一种用于糖尿病性冠心病辅助治疗的药物组合物 | |
CN104940428A (zh) | 一种含有枸杞子的降血糖组合物及其用途 | |
CN104904948A (zh) | 一种苗家保健茶 | |
CN105055968B (zh) | 一种治疗糖尿病的中药组合物、其制备方法及应用 | |
JP2023152722A (ja) | 腎精不足に伴う皮膚、毛髪及び爪の症状又は状態の予防、改善又は緩和のための組成物 | |
CN105031033A (zh) | 一种含有枸杞叶的食品、保健品或药物组合物 | |
WO2023074459A1 (ja) | 痰湿に関連する症状の予防、改善又は緩和のための組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170623 Address after: 350200 Fujian city of Fuzhou province Changle City Jinfeng town six village forest tycoon 166 Applicant after: Zhang Kechi Address before: 350015 (), room 1#2-4N, No. 27, Lake Road, Mawei District, Fujian, China Applicant before: Fujian trillion ecommerce Co., Ltd of shop-within-a-shop |
|
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161116 |